SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is trending amid market volatility driven by concerns over rising Treasury yields, higher oil prices, and uncertainty surrounding the pace of artificial intelligence development. Traders are closely monitoring the upcoming Federal Reserve policy meeting, with most expecting a rate hike.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as traders grapple with rising long-term Treasury yields and shifting expectations for a potential Federal Reserve rate hike in the face of persistent inflation. The conversation is dominated by debate over whether the Fed will maintain current rates or implement a hike, with many participants expressing skepticism about government intervention efforts to stabilize bond prices.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing volatility as traders debate the impact of broader market uncertainty and mixed signals regarding AI development, with many investors maintaining bullish long-term sentiment based on the company's foundry prospects. While some react to speculative rumors about potential partnerships, others are focusing on the stock's technical price action and technical support levels.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, and Defense. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce is trending as investors anticipate upcoming half-year earnings and updates on potential major hyperscaler data center contracts. The conversation is driven by the company's strong performance across its Civil Aerospace, Defence, and Power Systems divisions, alongside ongoing community enthusiasm for its small modular reactor (SMR) development.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending as traders react to the early completion of enrollment for the Phase 3 APPROACH trial of HLP003, while also digesting the impact of a recent equity offering. Community sentiment remains focused on the company's potential as an acquisition target and its upcoming late-stage clinical readouts compared to sector peers.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment shares are receiving significant attention following the announcement of a multi-million dollar contract for its directed-energy counter-drone laser systems. Traders are debating whether this development and the company's strong, record-breaking backlog will catalyze a price recovery, with many expressing frustration over the stock's recent downward performance despite positive fundamental news.

Nasdaq, Inc. is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information, and public and private company services. It operates through the following segments: Capital Access Platforms, Financial Technology, and Market Services. The Capital Access Platforms segment delivers liquidity, transparency, and integrity to the corporate issuer and investment community by empowering clients to effectively navigate the capital markets, achieve their sustainability goals, and drive governance excellence. The Financial Technology segment offers platforms that improve the liquidity, transparency, and integrity of the global economy by architecting and operating the markets. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income, currency, and commodities trading. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.

Nasdaq Inc - Ordinary Shares - 144A

Nasdaq Inc

Nasdaq Inc. is trending as investors monitor its move to introduce 23-hour trading sessions, which aims to provide near-continuous market access and increase global trading volume. Additionally, the company is drawing attention for recent investments in Kraken parent Payward and the acquisition of the AI-powered due diligence platform Dasseti, reflecting its broader strategy to expand fintech and private market capabilities.

Zoracles

Zoracles is experiencing increased community attention and volatility as traders debate the potential for a short squeeze driven by high future contract positions relative to its market cap. While some investors remain bullish on long-term growth and utility, others express frustration over extended price stagnation and characterize the project as a speculative pump and dump.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

The community is discussing Onyx's official completion of the acquisition of Chain technology and intellectual property, with many traders viewing the integration into the Onyx Layer 1 and Wallet as a critical step toward real-world neobank adoption. While some participants are bullish about this foundational shift, others remain skeptical, dismissing the movement as a repeat of previous pump-and-dump cycles.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as the community anticipates the upcoming release of Phase 2 maintenance trial data for VK2735, which is expected before the end of the quarter. Traders are actively debating the timing of this readout and the potential for a strategic partnership or buyout, though sentiment remains divided between those expecting significant upside and others frustrated by the stock's recent price stagnation and management's communication style.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
